Akihiro Kobayashi
President chez KOBAYASHI PHARMACEUTICAL CO., LTD.
Fortune : 312 M $ au 31/03/2024
Profil
Akihiro Kobayashi occupe le poste de président et directeur représentatif de Kobayashi Pharmaceutical Co., Ltd. M. Kobayashi est également membre du conseil d'administration de Medicon, Inc. (Japon).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 9 264 000 ( 11,87% ) | 312 M $ | 31/03/2024 |
Postes actifs de Akihiro Kobayashi
| Sociétés | Poste | Début |
|---|---|---|
| KOBAYASHI PHARMACEUTICAL CO., LTD. | President | 01/06/2013 |
Medicon, Inc. (Japan)
 Medicon, Inc. (Japan) Medical SpecialtiesHealth Technology Medicon, Inc. (Japan) manufactures, imports and sells medical equipment. It offers products related to the following: urination care, end yuro biology, critical care, catheter fixed, radiation therapy, interactive voice response (IVR), biopsy, hernia surgery, surgery, percutaneous endoscopic gastronomy (PEG), intravenous nutrition and chemotherapy, and dialysis. The company was founded on June 2, 1972 and is headquartered in Osaka City. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Kobayashi Pharmaceutical Co., Ltd. | |
Medicon, Inc. (Japan)
Medicon, Inc. (Japan) Medical SpecialtiesHealth Technology Medicon, Inc. (Japan) manufactures, imports and sells medical equipment. It offers products related to the following: urination care, end yuro biology, critical care, catheter fixed, radiation therapy, interactive voice response (IVR), biopsy, hernia surgery, surgery, percutaneous endoscopic gastronomy (PEG), intravenous nutrition and chemotherapy, and dialysis. The company was founded on June 2, 1972 and is headquartered in Osaka City. | Health Technology |
